Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | March 17, 2021 | News story | Research and Development | COVID-19, covid-19 roundup, news roundup
The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout Europe due to blood-clotting fears, while Johnson & Johnson’s one-dose vaccine has been approved by the European Commission, and Eli Lilly’s treatment showed an efficacy of 87% in a Phase III trial.
1. AstraZeneca vaccine suspended in 11 European countries – Published 16/03/2021
Blood clot fears have caused 11 European countries to suspend the use of the Oxford-AstraZeneca vaccine.
2. Netherlands suspends AstraZeneca vaccine despite safety assurances – Published 15/03/21
The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca vaccine amid concerns it may cause blood clotting, cancelling 43,000 vaccination appointments.
3. J&J’s one-shot COVID-19 vaccine approved by European Commission – Published 12/03/21
The European Commission has granted Johnson and Johnson’s single-shot COVID-19 vaccine Conditional Marketing Authorisation (CMA), it was announced on Thursday.
4. Novavax announces vaccine’s high efficacy against original and variant COVID-19 strains – Published – 12/03/21
Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in a pivotal UK Phase III trial of its vaccine NVX–CoV2373.
5. Eli Lilly’s COVID-19 treatment combination 87% effective in Phase III trial – Published 11/03/21
Eli Lilly has shown positive results in its Phase III combination drug trial, which reduced hospitalisations and deaths related to COVID-19.
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, …
